Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times

被引:41
作者
Takata, Saori [1 ]
Wada, Hiroo [1 ]
Tamura, Masaki [1 ]
Koide, Takashi [1 ]
Higaki, Manabu [1 ]
Mikura, Shin-ichiro [1 ]
Yasutake, Tetsuo [1 ]
Hirao, Susumu [1 ]
Nakamura, Masuo [1 ]
Honda, Koujiro [1 ]
Nagatomo, Tomoko [1 ]
Tanaka, Yasutaka [1 ]
Sohara, Erei [1 ]
Watanabe, Masato [1 ]
Yokoyama, Takuma [1 ]
Saraya, Takeshi [1 ]
Kurai, Daisuke [1 ]
Ishii, Haruyuki [1 ]
Goto, Hajime [1 ]
机构
[1] Kyorin Univ, Dept Resp Med, Sch Med, Tokyo 1818611, Japan
关键词
Community-acquired pneumonia (CAP); serum amyloid A (SAA); C-reactive protein (CRP); biologic half-life time; kinetics; PLASMA-CLEARANCE; MANAGEMENT; EXPRESSION;
D O I
10.3109/1354750X.2011.607189
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Context: In management of community-acquired pneumonia (CAP), excellent biomarkers for inflammation would be helpful in our practice. Objectives: Kinetics of c-reactive protein (CRP) and serum amyloid A (SAA) was characterized, using their biologic half-life times. Materials and methods: Time course of CRP and SAA levels in the successfully treated 36 CAP patients were investigated and their half-life times were determined and compared. Results & Discussions: SAA and CRP declined in an exponential mean and the biologic half-life times of SAA levels was 34.9 +/- 28.7 h, significantly shorter than that of CRP, 46.4 +/- 21.7 h (p = 0.0014). Conclusion: The kinetic evidence, presented as biologic half-life times of CRP and SAA, helps us make a clinical assessment of CAP patients.
引用
收藏
页码:530 / 535
页数:6
相关论文
共 17 条
  • [1] Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease
    Bozinovski, Steven
    Hutchinson, Anastasia
    Thompson, Michelle
    MacGregor, Lochlan
    Black, James
    Giannakis, Eleni
    Karlsson, Anne-Sophie
    Silvestrini, Roger
    Smallwood, David
    Vlahos, Ross
    Irving, Louis B.
    Anderson, Gary P.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (03) : 269 - 278
  • [2] Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course
    Coelho, Luis
    Póvoa, Pedro
    Almeida, Eduardo
    Fernandes, Antero
    Mealha, Rui
    Moreira, Pedro
    Sabino, Henrique
    [J]. CRITICAL CARE, 2007, 11 (04)
  • [3] *COMM JAP RESP SOC, 2006, NIHON KOKYUKI GAKK S, V45, P2
  • [4] Committee for The Japanese Respiratory Society guidelines for the management of respiratory infections, 2006, Respirology, V11, pS79
  • [6] A single intravenous dose of endotoxin rapidly alters serum lipoproteins and lipid transfer proteins in normal volunteers
    Hudgins, LC
    Parker, TS
    Levine, DM
    Gordon, BR
    Saal, SD
    Liang, XC
    Seidman, CE
    Tremaroli, JD
    Lai, J
    Rubin, AL
    [J]. JOURNAL OF LIPID RESEARCH, 2003, 44 (08) : 1489 - 1498
  • [7] Regulation of serum amyloid A protein expression during the acute-phase response
    Jensen, LE
    Whitehead, AS
    [J]. BIOCHEMICAL JOURNAL, 1998, 334 : 489 - 503
  • [8] Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women - The National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE)
    Johnson, BD
    Kip, KE
    Marroquin, OC
    Ridker, PM
    Kelsey, SF
    Shaw, LJ
    Pepine, CJ
    Sharaf, B
    Merz, CNB
    Sopko, G
    Olson, MB
    Reis, SE
    [J]. CIRCULATION, 2004, 109 (06) : 726 - 732
  • [9] Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis
    Kindy, MS
    King, AR
    Yu, J
    Gerardot, C
    Whitley, J
    de Beer, FC
    [J]. BIOCHEMICAL JOURNAL, 1998, 332 : 721 - 728
  • [10] Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2
    KluveBeckerman, B
    Yamada, T
    Hardwick, J
    Liepnieks, JJ
    Benson, MD
    [J]. BIOCHEMICAL JOURNAL, 1997, 322 : 663 - 669